- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01404897
Effects of High Fruit, Vegetable, and Dairy Intake on Plasma Lipids and Blood Pressure in Healthy Individuals
March 25, 2015 updated by: UCSF Benioff Children's Hospital Oakland
Effects of a Modified Lower Carbohydrate, Higher Fat DASH Diet Plan on Plasma Lipids, Lipoprotein Particle Size, and Blood Pressure in Healthy Adults
The Dietary Approaches to Stop Hypertension (DASH) trial has been shown to reduce blood pressure and plasma total and LDL-cholesterol (C) compared to a Western diet, but shows no benefit on other blood lipid variables associated with cardiovascular disease (CVD) risk, namely HDL-cholesterol and triglycerides.
The overall objective of this study is to determine whether modification of the DASH diet by substituting carbohydrate with fat will result in improvements in multiple biomarkers of CVD risk.
Specifically, the investigators will test the hypotheses that modification of the DASH diet by reducing carbohydrate, primarily in the form of simple sugars and glycemic starches, and allowing for a more liberal intake of total and saturated fat, primarily from dairy foods, will: (1) improve lipoprotein markers of CVD risk (reduced total/HDL-C ratio, apolipoprotein B, small LDL particles, and increased HDL-C, apoAI, and large HDL particles); and (2) result in comparable reductions of systolic and diastolic blood pressure to those achieved with the standard DASH diet.
The investigators will also assess the effects of the modified DASH diet on markers of insulin resistance and inflammation.
Our main hypotheses will be tested by a controlled dietary intervention conducted in 40 healthy men and women who will be randomly allocated to consume, for 3 weeks each, a control Western diet, a standard DASH diet, and a modified low-carbohydrate DASH diet, separated by 2-week washout periods.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
36
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Berkeley, California, United States, 94705
- Cholesterol Research Center, Children's Hospital Oakland Research Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
22 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 22 years and older
- Average systolic blood pressure <160 mm Hg and diastolic blood pressure 80 - 95 mm Hg measured on 2 separate days
- Non-smoking
- Agrees to abstain from alcohol and dietary supplements during the study
- Willing to consume all study foods as instructed
Exclusion Criteria:
- History of coronary heart disease, cerebrovascular disease, peripheral vascular disease, bleeding disorder, liver or renal disease, diabetes, lung disease, HIV, or cancer (other than skin cancer) in the last 5 years.
- Taking hormones or drugs known to affect lipid metabolism or blood pressure.
- Body Mass Index (BMI) > 35
- Total- and LDL-cholesterol > 95th percentile for sex and age.
- Fasting triglycerides > 500 mg/dl.
- Fasting blood sugar (FBS) > 126 mg/dl.
- Abnormal thyroid stimulating hormone
- Not weight stable
- Pregnant or breast-feeding
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Dietary Intervention: Control Diet
|
3 weeks of a typical Western diet pattern.
48% carbohydrate, 15% protein, 37% fat.
3 weeks of a diet based on the Dietary Approaches to Stop Hypertension (DASH) diet plan.
57% carbohydrate, 18% protein, 25% fat.
3 weeks of a reduced carbohydrate, higher fat modification of the DASH diet plan.
42% carbohydrate, 18% protein, 40% fat.
|
Experimental: Dietary Intervention: DASH-based diet
|
3 weeks of a typical Western diet pattern.
48% carbohydrate, 15% protein, 37% fat.
3 weeks of a diet based on the Dietary Approaches to Stop Hypertension (DASH) diet plan.
57% carbohydrate, 18% protein, 25% fat.
3 weeks of a reduced carbohydrate, higher fat modification of the DASH diet plan.
42% carbohydrate, 18% protein, 40% fat.
|
Experimental: Dietary Intervention: Modified DASH diet
|
3 weeks of a typical Western diet pattern.
48% carbohydrate, 15% protein, 37% fat.
3 weeks of a diet based on the Dietary Approaches to Stop Hypertension (DASH) diet plan.
57% carbohydrate, 18% protein, 25% fat.
3 weeks of a reduced carbohydrate, higher fat modification of the DASH diet plan.
42% carbohydrate, 18% protein, 40% fat.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Total:HDL-cholesterol ratio
Time Frame: 4 weeks
|
4 weeks
|
HDL-cholesterol
Time Frame: 4 weeks
|
4 weeks
|
Apolipoprotein B
Time Frame: 4 weeks
|
4 weeks
|
Apolipoprotein AI
Time Frame: 4 weeks
|
4 weeks
|
Small LDL particles
Time Frame: 4 weeks
|
4 weeks
|
Large HDL particles
Time Frame: 4 weeks
|
4 weeks
|
Total:HDL-cholesterol ratio
Time Frame: 9 weeks
|
9 weeks
|
Total:HDL-cholesterol ratio
Time Frame: 14 weeks
|
14 weeks
|
HDL-cholesterol
Time Frame: 9 weeks
|
9 weeks
|
HDL-cholesterol
Time Frame: 14 weeks
|
14 weeks
|
Apolipoprotein B
Time Frame: 9 weeks
|
9 weeks
|
Apolipoprotein B
Time Frame: 14 weeks
|
14 weeks
|
Apolipoprotein AI
Time Frame: 9 weeks
|
9 weeks
|
Apolipoprotein AI
Time Frame: 14 weeks
|
14 weeks
|
Small LDL particles
Time Frame: 9 weeks
|
9 weeks
|
Small LDL particles
Time Frame: 14 weeks
|
14 weeks
|
Large HDL particles
Time Frame: 9 weeks
|
9 weeks
|
Large HDL particles
Time Frame: 14 weeks
|
14 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Blood Pressure
Time Frame: End of each experimental diet (4 wks, 9 wks, and 14 wks)
|
End of each experimental diet (4 wks, 9 wks, and 14 wks)
|
Triglycerides
Time Frame: End of each experimental diet (4 wks, 9 wks, and 14 wks)
|
End of each experimental diet (4 wks, 9 wks, and 14 wks)
|
Total Cholesterol
Time Frame: End of each experimental diet (4 wks, 9 wks, and 14 wks)
|
End of each experimental diet (4 wks, 9 wks, and 14 wks)
|
LDL-Cholesterol
Time Frame: End of each experimental diet (4 wks, 9 wks, and 14 wks)
|
End of each experimental diet (4 wks, 9 wks, and 14 wks)
|
Lipoprotein Subclasses (HDL, LDL, IDL, VLDL)
Time Frame: End of each experimental diet (4 wks, 9 wks, and 14 wks)
|
End of each experimental diet (4 wks, 9 wks, and 14 wks)
|
HOMA-IR
Time Frame: End of each experimental diet (4 wks, 9 wks, and 14 wks)
|
End of each experimental diet (4 wks, 9 wks, and 14 wks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2011
Primary Completion (Actual)
December 1, 2013
Study Completion (Actual)
December 1, 2013
Study Registration Dates
First Submitted
July 22, 2011
First Submitted That Met QC Criteria
July 27, 2011
First Posted (Estimate)
July 28, 2011
Study Record Updates
Last Update Posted (Estimate)
March 26, 2015
Last Update Submitted That Met QC Criteria
March 25, 2015
Last Verified
March 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MM3274
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Disease
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedCardiovascular Disease | Inflammatory DiseaseUnited States
-
Morehouse School of MedicineNot yet recruiting
-
Yonsei UniversityRecruitingCardiovascular DiseaseKorea, Republic of
-
Nanjing Medical UniversityNot yet recruitingCardiovascular Disease
-
National Human Genome Research Institute (NHGRI)Active, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruiting
-
AmgenCompletedCardiovascular DiseaseUnited States, Australia
-
VA Office of Research and DevelopmentEnrolling by invitationCardiovascular DiseaseUnited States
Clinical Trials on Dietary Intervention
-
University of ViennaCompletedEndotoxemia | Dietary HabitsAustria
-
Azienda Ospedaliero-Universitaria CareggiRecruiting
-
Brown UniversityNational Cancer Institute (NCI)UnknownUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Brown UniversityNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
University of California, San FranciscoCompletedStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
Josephine Ford Cancer CenterNational Cancer Institute (NCI)UnknownUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
University Hospital, Strasbourg, FranceRecruitingDigestive Cancer | UndernourishedFrance
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedRectal Cancer | Colon Cancer | Cancer Survivor | Colorectal Adenocarcinoma | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage... and other conditionsUnited States
-
University of South CarolinaAcademy of Nutrition and DieteticsCompleted
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedCaloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast CancerBreast Carcinoma | Endometrial Carcinoma | Prostate CarcinosarcomaUnited States